Browsing: Blog

Exclusive

Extel Plans New MiFID II Service

10/30/2017
Extel, which provides the most prestigious survey of European buy-side research preferences, will be launching a new service inspired by pending MiFID II reforms to research payments, according to informed ...
Exclusive

Will Research Unbundling Prove To Be A “Mifxit”?

10/25/2017
The following is a guest article written by Fabrice Bouland, CEO and co-founder of Paris-based research portal Alphametry. Research unbundling is nearly upon us. The intense debate around its emergence ...
Exclusive

Why I Left the Bulge Bracket Behind

10/23/2017
The following is a guest article by Dan Sanders, who joined Olivetree Financial last month as Head of US Execution Services after a sixteen-year bulge bracket career, most recently as ...
Exclusive

Caution: Shifting Research Costs To P&L Does Not Eliminate Inducement Risk

10/18/2017
The following is a guest article from John McGough, Global Head of Business Development of Castine LLC, a provider of research procurement solutions including P&L Centre. Recently, a fair number of ...
Exclusive

The Resurgence of Quantitative Investing

10/16/2017
The following is a guest article from Hui Wang, Partner of AlphaLetters LLC, a service which monitors new quantitative finance research from universities, finance journals associations and other sources. 2017 ...
Exclusive

Alternative Data Providers For Top China Equities

10/10/2017
The following is an article that will be published by Alternativedata.org, an informational website about alternative data supported by YipitData and other contributors. Alternativedata.org identified the 17 largest equities in China, ...

Seaport Global Securities Adds Healthcare Coverage

10/09/2017
Regional investment bank Seaport Global Securities, recently announced the addition of Managing Director and Senior biotechnology and specialty pharmaceuticals analyst Vernon Bernardino.  With the addition of Bernardino, Seaport is launching ...
Exclusive

Bellwether Research Valuations Continue to Improve in Q3 2017

10/04/2017
According to analysis prepared exclusively for Integrity Research by Marlin & Associates[1], the international M&A advisor, average valuations for large publicly traded research and information firms increased in the third ...

Biotech Analyst Charged with Insider Trading

10/02/2017
A former Zacks biotech analyst and two employees of Chicago–based brokerage firm, LBMZ Securities, were recently charged with insider trading for alleged activity taken by the three between 2012 and ...
Exclusive

Stock Correlations Fall Back to Pre-Crisis Levels

09/28/2017
As we noted in January, market conditions for stock pickers – and fundamental equity research providers – have improved as stocks are less likely to move in lock step than ...
1 2 3 4 5 91